117 related articles for article (PubMed ID: 37293010)
1. Decreasing the flexibility of the TELSAM-target protein linker and omitting the cleavable fusion tag improves crystal order and diffraction limits.
Gajjar PL; Romo MJP; Litchfield CM; Callahan M; Redd N; Nawarathnage S; Soleimani S; Averett J; Wilson E; Lewis A; Stewart C; Tseng YJ; Doukov T; Lebedev A; Moody JD
bioRxiv; 2023 May; ():. PubMed ID: 37293010
[TBL] [Abstract][Full Text] [Related]
2. Increasing the bulk of the 1TEL-target linker and retaining the 10×His tag in a 1TEL-CMG2-vWa construct improves crystal order and diffraction limits.
Gajjar PL; Pedroza Romo MJ; Litchfield CM; Callahan M; Redd N; Nawarathnage S; Soleimani S; Averett J; Wilson E; Lewis A; Stewart C; Tseng YJ; Doukov T; Lebedev A; Moody JD
Acta Crystallogr D Struct Biol; 2023 Oct; 79(Pt 10):925-943. PubMed ID: 37747038
[TBL] [Abstract][Full Text] [Related]
3. Crystals of TELSAM-target protein fusions that exhibit minimal crystal contacts and lack direct inter-TELSAM contacts.
Nawarathnage S; Soleimani S; Mathis MH; Bezzant BD; Ramírez DT; Gajjar P; Bunn DR; Stewart C; Smith T; Pedroza Romo MJ; Brown S; Doukov T; Moody JD
Open Biol; 2022 Mar; 12(3):210271. PubMed ID: 35232248
[TBL] [Abstract][Full Text] [Related]
4. Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domain.
Nawarathnage S; Tseng YJ; Soleimani S; Smith T; Pedroza Romo MJ; Abiodun WO; Egbert CM; Madhusanka D; Bunn D; Woods B; Tsubaki E; Stewart C; Brown S; Doukov T; Andersen JL; Moody JD
Structure; 2023 Dec; 31(12):1589-1603.e6. PubMed ID: 37776857
[TBL] [Abstract][Full Text] [Related]
5. Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domain.
Nawarathnage S; Tseng YJ; Soleimani S; Smith T; Romo MJP; Abiodun WO; Egbert CM; Madhusanka D; Bunn D; Woods B; Tsubaki E; Stewart C; Brown S; Doukov T; Andersen JL; Moody JD
bioRxiv; 2023 Jun; ():. PubMed ID: 37398013
[TBL] [Abstract][Full Text] [Related]
6. Symmetry based assembly of a 2 dimensional protein lattice.
Poulos S; Agah S; Jallah N; Faham S
PLoS One; 2017; 12(4):e0174485. PubMed ID: 28419162
[TBL] [Abstract][Full Text] [Related]
7. The macro domain as fusion tag for carrier-driven crystallization.
Wild R; Hothorn M
Protein Sci; 2017 Feb; 26(2):365-374. PubMed ID: 27774698
[TBL] [Abstract][Full Text] [Related]
8. Polymer-driven crystallization.
Nauli S; Farr S; Lee YJ; Kim HY; Faham S; Bowie JU
Protein Sci; 2007 Nov; 16(11):2542-51. PubMed ID: 17962407
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin as a fusion tag for carrier-driven crystallization.
Corsini L; Hothorn M; Scheffzek K; Sattler M; Stier G
Protein Sci; 2008 Dec; 17(12):2070-9. PubMed ID: 18780816
[TBL] [Abstract][Full Text] [Related]
10. Development of a robust crystallization platform for immune receptor TREM2 using a crystallization chaperone strategy.
Byrne NJ; Lee AC; Kostas J; Reid JC; Partridge AT; So SS; Cowan JE; Abeywickrema P; Huang H; Zebisch M; Barker JJ; Soisson SM; Brooun A; Su HP
Protein Expr Purif; 2021 Mar; 179():105796. PubMed ID: 33221505
[TBL] [Abstract][Full Text] [Related]
11. A posteriori design of crystal contacts to improve the X-ray diffraction properties of a small RNA enzyme.
MacElrevey C; Spitale RC; Krucinska J; Wedekind JE
Acta Crystallogr D Biol Crystallogr; 2007 Jul; 63(Pt 7):812-25. PubMed ID: 17582172
[TBL] [Abstract][Full Text] [Related]
12. Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.
Argiriadi MA; Goedken ER; Banach D; Borhani DW; Burchat A; Dixon RW; Marcotte D; Overmeyer G; Pivorunas V; Sadhukhan R; Sousa S; Moore NS; Tomlinson M; Voss J; Wang L; Wishart N; Woller K; Talanian RV
BMC Struct Biol; 2012 Sep; 12():22. PubMed ID: 22995073
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of MBP fusion proteins.
Waugh DS
Protein Sci; 2016 Mar; 25(3):559-71. PubMed ID: 26682969
[TBL] [Abstract][Full Text] [Related]
14. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1.
Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026
[TBL] [Abstract][Full Text] [Related]
15. Expression of Antimicrobial Peptide (AMP), Cecropin B, in a Fused Form to SUMO Tag With or Without Three-Glycine Linker in Escherichia coli and Evaluation of Bacteriolytic Activity of the Purified AMP.
Park AR; Kim SW; Kim SY; Kwon KC
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1780-1789. PubMed ID: 34018140
[TBL] [Abstract][Full Text] [Related]
16. Second SH3 domain of ponsin solved from powder diffraction.
Margiolaki I; Wright JP; Wilmanns M; Fitch AN; Pinotsis N
J Am Chem Soc; 2007 Sep; 129(38):11865-71. PubMed ID: 17784760
[TBL] [Abstract][Full Text] [Related]
17. Functionalization of the BCL6 BTB domain into a noncovalent crystallization chaperone.
Zacharchenko T; Wright S
IUCrJ; 2021 Mar; 8(Pt 2):154-160. PubMed ID: 33708392
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of papain-succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide complex at 1.7-A resolution: noncovalent binding mode of a common sequence of endogenous thiol protease inhibitors.
Yamamoto A; Tomoo K; Doi M; Ohishi H; Inoue M; Ishida T; Yamamoto D; Tsuboi S; Okamoto H; Okada Y
Biochemistry; 1992 Nov; 31(46):11305-9. PubMed ID: 1445868
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification and crystallization of the photosensory module of phytochrome B (phyB) from Sorghum bicolor.
Shenkutie SM; Nagano S; Hughes J
Acta Crystallogr F Struct Biol Commun; 2024 Mar; 80(Pt 3):59-66. PubMed ID: 38376821
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
